Restructuring Initiatives are On Track
and Delivering Significant Margin Improvement
GAAP Gross Margin of 29.7%; Adjusted Gross
Margin Improved 340bps versus Last Year to 40.5%
Adjusted EBITDA Loss Narrowed Notably to
$(6.4) Million versus $(16.3) Million Last Year
LEHI,
Utah, Nov. 4, 2024 /PRNewswire/ -- Purple
Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation
company known for creating the "World's First No Pressure™
Mattress," today announced results for the third quarter ended
September 30, 2024.
"While our third quarter revenue was challenged, we are
encouraged by both our year-to-date performance modestly exceeding
the broader industry and the sustained improvements in our
profitability," said CEO Rob
DeMartini.
"The restructuring plan we announced earlier this quarter is on
track to deliver meaningful cost savings in the new year as we
improve our operational efficiencies and positions us to capitalize
on tailwinds when the market improves. Looking forward, we remain
confident in our Path to Premium Sleep strategy's ability to
deliver long-term value and we look forward to building on this
momentum into 2025."
Third Quarter 2024 Financial Results
Third quarter 2024 net revenue declined by 15.3% to $118.6 million, compared to $140.0 million in the third quarter of 2023. This
decrease was primarily driven by industry-wide demand softness for
home-related products, a reduction in advertising spend towards
more profitable marketing, and the lapping of our successful launch
of new premium mattresses in 2023. By channel, DTC net revenues
decreased 11.7%, and wholesale net revenues decreased 20.1%. Within
DTC, e-commerce net revenues decreased 15.7%, while showroom net
revenues were approximately flat. In addition to the factors above,
the decline in wholesale net revenues reflected the exit of certain
customers.
Gross margin for the third quarter of 2024 decreased to 29.7%
down 410 basis points compared to 33.8% in the prior year,
negatively impacted by the $12.9
million of restructuring related charges offset in part by
improved production efficiencies. The increase in production
efficiencies was primarily due to supply chain initiatives and
manufacturing efficiencies. We expect the restructuring plan will
further streamline our operations and provide increased gross
profits. Despite deleveraging from lower sales, adjusted gross
margin, which excludes restructuring related charges during the
quarter and launch costs in the prior year period, grew to 40.5%,
an increase of 340 basis points compared to adjusted gross margin
last year.
Operating expenses for the third quarter were $82.0 million, up 2.6% from $79.9 million in Q3 2023. This increase was
driven by $19.8 million in
restructuring related charges as part of the consolidation of our
manufacturing operations to achieve significant operational
efficiencies. Excluding all restructuring related charges this year
and loss on impairment of goodwill last year, adjusted operating
expenses were down by $10.9 million,
primarily due to a $9.1 million
reduction in advertising spend.
Net loss attributable to Purple Innovation, Inc. for the third
quarter of 2024 was $(39.2) million
or $(0.36) per diluted share,
compared to a net loss of $(36.0)
million or $(0.34) per diluted
share in the third quarter 2023. Adjusted net loss, excluding
restructuring related charges and certain non-cash and one-time
items, was $(8.4) million or
$(0.08) per diluted share, an
improvement from $(19.4) million or
$(0.18) per diluted share in the
prior year.
EBITDA for the third quarter 2024 was $(27.4) million compared to $(29.7) million in the third quarter 2023.
Adjusted EBITDA was $(6.4) million,
an improvement from $(16.3) million
in the prior year.
Restructuring, Impairment and Other Related Charges
In August 2024, we initiated a
restructuring plan to strategically realign our operational focus
to achieve significant operational efficiencies. This plan includes
the closure of our two Utah
manufacturing facilities to consolidate mattress production to our
Georgia plant, as well as a
headcount reduction at our Utah
headquarters. As a result, we have a $32.7 million total restructuring, impairment and
other related charges in the third quarter 2024. We expect to
record additional restructuring and other related charges in the
amount of $9.9 million through the
second quarter of 2025. The supply chain consolidation and
corporate restructure is expected to yield annual EBITDA savings of
$15 to $20
million starting in 2025, and we plan to have positive cash
flow and adjusted EBITDA next year.
Balance Sheet
Cash and cash equivalents were $23.4
million as of September 30,
2024, compared to $26.9
million as of December 31,
2023.
Inventories as of September 30,
2024 totaled $59.9 million,
representing a decrease of 10.5%, or $7.0
million compared with December 31,
2023.
2024 Outlook
For the full year 2024, we expect to be at the lower end of our
guidance range for net revenue of $490
million to $510 million, and
also at the lower end of our guidance range for Adjusted EBITDA
outlook of $(20) million to
$(10) million. The company continues
to prioritize and benefit from operational improvements and expects
positive Adjusted EBITDA in the fourth quarter.
Conference Call and Webcast Information
Purple Innovation, Inc. will host a live conference call to
discuss financial results today, November 4,
2024 at 4:30 p.m. Eastern
Time. To access the call dial 844-481-1976 (domestic)
or 412-317-0642 (international). The call is also being webcast and
can be accessed on the investor relations section of the Company's
website, investors.purple.com. After the conference call, a webcast
replay will remain available on the investor relations section of
the Company's website for 30 days.
About Purple
Purple, the leading premium mattress company with the #1 Gel
Grid technology in the world, the GelFlex® Grid,
thoughtfully engineers products that make restorative sleep
effortless for every kind of sleeper. The result of over 30 years
of innovation and in comfort technologies, Purple's GelFlex Grid is
the most significant advancement in mattresses in decades and is
proven to reduce aches and pains. It instantly adapts as you move,
balances temperature, relieves pressure and offers support in all
the right places. Purple products, including mattresses, pillows,
cushions, frames, sheets, and more, can be found online
at Purple.com, in 59 Purple stores and over 3,000 retailers
nationwide. Sleep Better. Live Purple.
Forward Looking Statements
Certain statements made in this release that are not historical
facts are "forward looking statements" within the meaning of the
"safe harbor" provisions of the United States Private Securities
Litigation Reform Act of 1995. Statements based on historical data
are not intended and should not be understood to indicate the
Company's expectations regarding future events. Forward-looking
statements provide current expectations or forecasts of future
events or determinations. These forward-looking statements are not
guarantees of future performance, conditions or results, and
involve a number of known and unknown risks, uncertainties,
assumptions and other important factors, many of which are outside
the Company's control, that could cause actual results or outcomes
to differ materially from those discussed in the forward-looking
statements. Factors that could influence the realization of
forward-looking statements include, among others: changes in
economic, financial and end-market conditions in the markets in
which we operate; fluctuations in raw material prices and cost of
labor; the financial condition of our customers and suppliers;
competitive pressures, including the need for technology
improvement, successful new product development and introduction;
changes in consumer demand, including pullbacks in consumer
spending; disruptions to our manufacturing processes; and the risk
factors outlined in the "Risk Factors" section of our Annual Report
on Form 10-K filed with the Securities and Exchange Commission on
March 12, 2024, and in our other
filings made with the SEC. The Company does not undertake any
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as required by law.
Non-GAAP Financial Measures
EBITDA, adjusted EBITDA, adjusted net income, and adjusted net
income per diluted share are non-GAAP financial measures that
remove the impact of certain non-cash and non-recurring costs.
Management believes that the use of such non-GAAP financial
measures provides investors with additional useful information with
respect to the impact of various adjustments, which we view as a
better measure of our operating performance. Refer to the attached
table for the reconciliation of such non-GAAP financial measures to
the most comparable GAAP financial measure.
With respect to the Company's Adjusted EBITDA outlook for the
third quarter and full year 2024, a quantitative reconciliation to
the corresponding GAAP information cannot be provided without
unreasonable effort because of the inherent difficulty of
accurately forecasting the occurrence and financial impact of the
various adjusting items necessary for such reconciliation that have
not yet occurred, are out of our control, or cannot be reasonably
predicted, including but not limited to warrant liabilities and
stock based compensation. For the same reasons, the Company is
unable to assess the probable significance of the unavailable
information, which could have a material impact on its future GAAP
financial results.
Investor Contact:
Stacy
Turnof, Edelman
Smithfield
stacy.turnof@edelmansmithfield.com
917-362-2581
PURPLE INNOVATION,
INC. Condensed Consolidated Balance
Sheets (unaudited – in thousands, except for par
value)
|
|
|
|
September 30,
2024
|
|
|
December 31,
2023
|
|
Assets
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
23,399
|
|
|
$
|
26,857
|
|
Accounts receivable, net
|
|
|
29,662
|
|
|
|
37,802
|
|
Inventories
|
|
|
59,881
|
|
|
|
66,878
|
|
Prepaid expenses
|
|
|
9,241
|
|
|
|
8,536
|
|
Other current assets
|
|
|
1,005
|
|
|
|
1,737
|
|
Total current
assets
|
|
|
123,188
|
|
|
|
141,810
|
|
Property and equipment,
net
|
|
|
100,155
|
|
|
|
128,661
|
|
Operating lease
right-of-use assets
|
|
|
74,254
|
|
|
|
95,767
|
|
Intangible assets,
net
|
|
|
9,226
|
|
|
|
22,196
|
|
Other long-term
assets
|
|
|
2,450
|
|
|
|
2,191
|
|
Total assets
|
|
$
|
309,273
|
|
|
$
|
390,625
|
|
|
|
|
|
|
|
|
|
|
Liabilities and
Stockholders' Equity
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
30,393
|
|
|
$
|
49,831
|
|
Accrued compensation
|
|
|
15,109
|
|
|
|
5,064
|
|
Customer prepayments
|
|
|
3,778
|
|
|
|
5,718
|
|
Accrued rebates and allowances
|
|
|
10,040
|
|
|
|
13,243
|
|
Accrued warranty liabilities – current portion
|
|
|
7,634
|
|
|
|
9,793
|
|
Operating lease obligations – current portion
|
|
|
16,157
|
|
|
|
14,843
|
|
Other current liabilities
|
|
|
11,353
|
|
|
|
12,490
|
|
Total current
liabilities
|
|
|
94,464
|
|
|
|
110,982
|
|
Related party
debt
|
|
|
50,813
|
|
|
|
—
|
|
Long-term debt, net of
current portion
|
|
|
—
|
|
|
|
26,909
|
|
Accrued warranty
liabilities, net of current portion
|
|
|
27,336
|
|
|
|
25,798
|
|
Operating lease
obligations, net of current portion
|
|
|
85,621
|
|
|
|
109,094
|
|
Warrant
liabilities
|
|
|
19,682
|
|
|
|
—
|
|
Other long-term
liabilities
|
|
|
3,344
|
|
|
|
2,235
|
|
Total
liabilities
|
|
|
281,260
|
|
|
|
275,018
|
|
Commitments and
contingencies (Note 14)
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
|
|
Class A common stock; $0.0001 par value, 210,000 shares
authorized; 107,516
issued and outstanding at
September 30, 2024 and 105,507 issued and
outstanding at December
31, 2023
|
|
|
11
|
|
|
|
11
|
|
Class B common stock; $0.0001 par value, 90,000 shares
authorized; 192 issued
and outstanding at
September 30, 2024 and at December 31, 2023
|
|
|
—
|
|
|
|
—
|
|
Additional paid-in capital
|
|
|
593,343
|
|
|
|
591,380
|
|
Accumulated deficit
|
|
|
(565,387)
|
|
|
|
(475,969)
|
|
Total stockholders'
equity attributable to Purple Innovation, Inc.
|
|
|
27,967
|
|
|
|
115,422
|
|
Noncontrolling interest
|
|
|
46
|
|
|
|
185
|
|
Total stockholders'
equity
|
|
|
28,013
|
|
|
|
115,607
|
|
Total liabilities and
stockholders' equity
|
|
$
|
309,273
|
|
|
$
|
390,625
|
|
PURPLE INNOVATION,
INC. Condensed Consolidated Statements of
Operations (unaudited – in thousands, except per share
amounts)
|
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Revenues,
net
|
|
$
|
118,598
|
|
|
$
|
139,996
|
|
|
$
|
358,902
|
|
|
$
|
364,605
|
|
Cost of
revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of
revenues
|
|
|
70,546
|
|
|
|
92,687
|
|
|
|
220,190
|
|
|
|
241,244
|
|
Cost of revenues -
restructuring related charges
|
|
|
12,859
|
|
|
|
—
|
|
|
|
12,859
|
|
|
|
—
|
|
Total cost of
revenues
|
|
|
83,405
|
|
|
|
92,687
|
|
|
|
233,049
|
|
|
|
241,244
|
|
Gross profit
|
|
|
35,193
|
|
|
|
47,309
|
|
|
|
125,853
|
|
|
|
123,361
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketing and
sales
|
|
|
42,939
|
|
|
|
52,816
|
|
|
|
125,778
|
|
|
|
137,368
|
|
General and
administrative
|
|
|
17,266
|
|
|
|
17,524
|
|
|
|
55,111
|
|
|
|
67,628
|
|
Research and
development
|
|
|
2,920
|
|
|
|
2,704
|
|
|
|
10,572
|
|
|
|
9,001
|
|
Restructuring,
impairment and other related charges
|
|
|
18,881
|
|
|
|
—
|
|
|
|
18,881
|
|
|
|
—
|
|
Loss on impairment of
goodwill
|
|
|
—
|
|
|
|
6,879
|
|
|
|
—
|
|
|
|
6,879
|
|
Total operating
expenses
|
|
|
82,006
|
|
|
|
79,923
|
|
|
|
210,342
|
|
|
|
220,876
|
|
Operating
loss
|
|
|
(46,813)
|
|
|
|
(32,614)
|
|
|
|
(84,489)
|
|
|
|
(97,515)
|
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(4,394)
|
|
|
|
(594)
|
|
|
|
(13,029)
|
|
|
|
(1,148)
|
|
Other income,
net
|
|
|
7,165
|
|
|
|
205
|
|
|
|
11,612
|
|
|
|
315
|
|
Change in fair value –
warrant liabilities
|
|
|
4,795
|
|
|
|
—
|
|
|
|
(111)
|
|
|
|
—
|
|
Loss on extinguishment
of debt
|
|
|
—
|
|
|
|
(3,114)
|
|
|
|
(3,394)
|
|
|
|
(4,331)
|
|
Total other income
(expense), net
|
|
|
7,566
|
|
|
|
(3,503)
|
|
|
|
(4,922)
|
|
|
|
(5,164)
|
|
Net loss before income
taxes
|
|
|
(39,247)
|
|
|
|
(36,117)
|
|
|
|
(89,411)
|
|
|
|
(102,679)
|
|
Income tax
expense
|
|
|
(63)
|
|
|
|
(18)
|
|
|
|
(176)
|
|
|
|
(162)
|
|
Net loss
|
|
|
(39,310)
|
|
|
|
(36,135)
|
|
|
|
(89,587)
|
|
|
|
(102,841)
|
|
Net loss attributable
to noncontrolling interest
|
|
|
(82)
|
|
|
|
(131)
|
|
|
|
(169)
|
|
|
|
(417)
|
|
Net loss attributable
to Purple Innovation, Inc.
|
|
$
|
(39,228)
|
|
|
$
|
(36,004)
|
|
|
$
|
(89,418)
|
|
|
$
|
(102,424)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per
share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.36)
|
|
|
$
|
(0.34)
|
|
|
$
|
(0.84)
|
|
|
$
|
(0.99)
|
|
Diluted
|
|
$
|
(0.36)
|
|
|
$
|
(0.34)
|
|
|
$
|
(0.84)
|
|
|
$
|
(0.99)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common
shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
107,508
|
|
|
|
105,326
|
|
|
|
107,008
|
|
|
|
102,962
|
|
Diluted
|
|
|
107,508
|
|
|
|
105,326
|
|
|
|
107,008
|
|
|
|
102,962
|
|
PURPLE INNOVATION,
INC. Condensed Consolidated Statements of Cash
Flows (unaudited - in thousands)
|
|
|
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Cash flows from
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(39,310)
|
|
|
$
|
(36,135)
|
|
|
$
|
(89,587)
|
|
|
$
|
(102,841)
|
|
Adjustments to
reconcile net loss to net cash used in
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
14,627
|
|
|
|
6,073
|
|
|
|
27,448
|
|
|
|
18,963
|
|
Non-cash
interest
|
|
|
1,931
|
|
|
|
234
|
|
|
|
5,303
|
|
|
|
920
|
|
Paid-in-kind
interest
|
|
|
2,653
|
|
|
|
—
|
|
|
|
7,028
|
|
|
|
—
|
|
Non-cash restructuring,
impairment and other related
charges
|
|
|
20,115
|
|
|
|
—
|
|
|
|
20,115
|
|
|
|
—
|
|
Loss on impairment of
goodwill
|
|
|
—
|
|
|
|
6,879
|
|
|
|
—
|
|
|
|
6,879
|
|
Change in fair value –
warrant liabilities
|
|
|
(4,795)
|
|
|
|
—
|
|
|
|
111
|
|
|
|
—
|
|
Loss on extinguishment
of debt
|
|
|
—
|
|
|
|
3,114
|
|
|
|
3,394
|
|
|
|
4,331
|
|
Stock-based
compensation
|
|
|
791
|
|
|
|
939
|
|
|
|
2,108
|
|
|
|
3,792
|
|
Loss on disposal of
property and equipment
|
|
|
658
|
|
|
|
—
|
|
|
|
770
|
|
|
|
—
|
|
Changes in operating
assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
2,421
|
|
|
|
(10,002)
|
|
|
|
8,140
|
|
|
|
1,465
|
|
Inventories
|
|
|
5,750
|
|
|
|
5,757
|
|
|
|
2,971
|
|
|
|
696
|
|
Prepaid expenses and
other assets
|
|
|
(4,287)
|
|
|
|
(4,156)
|
|
|
|
378
|
|
|
|
(1,204)
|
|
Operating leases,
net
|
|
|
(765)
|
|
|
|
147
|
|
|
|
(2,105)
|
|
|
|
1,462
|
|
Accounts
payable
|
|
|
(7,036)
|
|
|
|
(2,760)
|
|
|
|
(16,558)
|
|
|
|
544
|
|
Accrued
compensation
|
|
|
5,923
|
|
|
|
1,908
|
|
|
|
10,045
|
|
|
|
(801)
|
|
Customer
prepayments
|
|
|
(954)
|
|
|
|
(302)
|
|
|
|
(1,940)
|
|
|
|
723
|
|
Accrued rebates and
allowances
|
|
|
1,405
|
|
|
|
2,748
|
|
|
|
(3,203)
|
|
|
|
(1,229)
|
|
Accrued warranty
liabilities
|
|
|
(462)
|
|
|
|
2,360
|
|
|
|
(621)
|
|
|
|
7,422
|
|
Other accrued
liabilities
|
|
|
2,454
|
|
|
|
5,441
|
|
|
|
1,592
|
|
|
|
3,070
|
|
Net cash provided by
(used in) operating activities
|
|
|
1,119
|
|
|
|
(17,755)
|
|
|
|
(24,611)
|
|
|
|
(55,808)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excess restricted cash
returned to acquiree
|
|
|
—
|
|
|
|
(826)
|
|
|
|
—
|
|
|
|
(826)
|
|
Purchase of property
and equipment
|
|
|
(1,018)
|
|
|
|
(3,326)
|
|
|
|
(6,160)
|
|
|
|
(8,769)
|
|
Investment in
intangible assets
|
|
|
(110)
|
|
|
|
(208)
|
|
|
|
(221)
|
|
|
|
(588)
|
|
Net cash used in
investing activities
|
|
|
(1,128)
|
|
|
|
(4,360)
|
|
|
|
(6,381)
|
|
|
|
(10,183)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments on term
loan
|
|
|
—
|
|
|
|
—
|
|
|
|
(25,000)
|
|
|
|
(24,656)
|
|
Payments on revolving
line of credit
|
|
|
—
|
|
|
|
—
|
|
|
|
(5,000)
|
|
|
|
—
|
|
Proceeds from related
party loan
|
|
|
—
|
|
|
|
—
|
|
|
|
61,000
|
|
|
|
—
|
|
Proceeds from term
loan
|
|
|
—
|
|
|
|
25,000
|
|
|
|
—
|
|
|
|
25,000
|
|
Payments for debt
issuance costs
|
|
|
—
|
|
|
|
(3,228)
|
|
|
|
(3,466)
|
|
|
|
(6,126)
|
|
Proceeds from stock
offering
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
60,300
|
|
Payments for public
offering costs
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(3,301)
|
|
Proportional
Representation Preferred Linked Stock
redemption fee
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(105)
|
|
Tax receivable
agreement payments
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(269)
|
|
Net cash provided by
financing activities
|
|
|
—
|
|
|
|
21,772
|
|
|
|
27,534
|
|
|
|
50,843
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net decrease in
cash
|
|
|
(9)
|
|
|
|
(343)
|
|
|
|
(3,458)
|
|
|
|
(15,148)
|
|
Cash, beginning of the
period
|
|
|
23,408
|
|
|
|
26,949
|
|
|
|
26,857
|
|
|
|
41,754
|
|
Cash, end of the
period
|
|
$
|
23,399
|
|
|
$
|
26,606
|
|
|
$
|
23,399
|
|
|
$
|
26,606
|
|
PURPLE INNOVATION,
INC.
RECONCILIATION OF GAAP TO NON-GAAP
MEASURES
(In thousands)
Management believes that the use of the following non-GAAP
financial measures provides investors with additional useful
information with respect to the impact of various adjustments,
which we view as a better measure of our operating performance.
These non-GAAP financial measures are EBITDA, adjusted EBITDA,
adjusted net income, adjusted net income per diluted share and
adjusted gross profit. Other companies may calculate these non-GAAP
measures differently than we do. These non-GAAP measures have
limitations as analytical tools, and you should not consider them
in isolation or as a substitute for our financial results prepared
in accordance with GAAP.
Reconciliation of GAAP Net Income (Loss) to Non-GAAP EBITDA
and Adjusted EBITDA
A reconciliation of GAAP net loss to the non-GAAP measures of
EBITDA and adjusted EBITDA is provided below. EBITDA represents net
loss before interest expense, income tax (benefit) expense, other
(income) expense, net, and depreciation and amortization. Adjusted
EBITDA represents EBITDA excluding costs incurred due to changes in
the fair value of the warrant liability, debt extinguishment,
stock-based compensation expense, restructuring related charges,
vendor separation fees, loss on project write-off, impairment of
goodwill, nonrecurring legal fees, Board special committee costs,
acquisition expenses, executive interim and search costs, severance
costs and showroom opening and closing costs. We believe EBITDA and
Adjusted EBITDA provide additional useful information with respect
to the impact of various adjustments and provide meaningful
measures of our operating performance.
|
|
Three Months
Ended
September
30,
|
|
|
Nine Months
Ended
September
30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net
loss
|
|
$
|
(39,310)
|
|
|
|
(36,135)
|
|
|
|
(89,587)
|
|
|
|
(102,841)
|
|
Interest
expense
|
|
|
4,394
|
|
|
|
594
|
|
|
|
13,029
|
|
|
|
1,148
|
|
Income tax
expense
|
|
|
63
|
|
|
|
18
|
|
|
|
176
|
|
|
|
162
|
|
Other income,
net
|
|
|
(7,165)
|
|
|
|
(205)
|
|
|
|
(11,612)
|
|
|
|
(315)
|
|
Depreciation and
amortization
|
|
|
14,627
|
|
|
|
6,073
|
|
|
|
27,448
|
|
|
|
18,963
|
|
EBITDA
|
|
|
(27,391)
|
|
|
|
(29,655)
|
|
|
|
(60,546)
|
|
|
|
(82,883)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value -
warrant liability
|
|
|
(4,795)
|
|
|
|
—
|
|
|
|
111
|
|
|
|
—
|
|
Loss on extinguishment
of debt
|
|
|
—
|
|
|
|
3,114
|
|
|
|
3,394
|
|
|
|
4,331
|
|
Stock-based
compensation expense
|
|
|
791
|
|
|
|
939
|
|
|
|
2,108
|
|
|
|
3,792
|
|
Restructuring related
charges
|
|
|
23,669
|
|
|
|
—
|
|
|
|
23,669
|
|
|
|
—
|
|
Vendor separation
fee
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,050
|
|
Loss on project
write-off
|
|
|
—
|
|
|
|
—
|
|
|
|
1,355
|
|
|
|
—
|
|
Loss on impairment of
goodwill
|
|
|
—
|
|
|
|
6,879
|
|
|
|
—
|
|
|
|
6,879
|
|
Legal fees
|
|
|
16
|
|
|
|
775
|
|
|
|
940
|
|
|
|
3,520
|
|
Board special committee
costs
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
14,160
|
|
Acquisition
expenses
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
65
|
|
Executive interim and
search costs
|
|
|
409
|
|
|
|
1,456
|
|
|
|
3,383
|
|
|
|
3,258
|
|
Severance
costs
|
|
|
202
|
|
|
|
—
|
|
|
|
1,086
|
|
|
|
586
|
|
Showroom opening and
closing costs
|
|
|
724
|
|
|
|
242
|
|
|
|
782
|
|
|
|
338
|
|
Adjusted
EBITDA
|
|
$
|
(6,375)
|
|
|
$
|
(16,250)
|
|
|
$
|
(23,718)
|
|
|
$
|
(44,904)
|
|
Reconciliation of GAAP Gross Margin to Adjusted Gross
Margin
A reconciliation of GAAP gross margin to the non-GAAP measures
of adjusted gross margin is provided below. Adjusted gross margin
represents adjusted net revenue less adjusted cost of revenue.
Adjusted net revenue represents revenue adjusted for revenue deemed
lost through discounts on products during our transition to our new
product line in 2023. Adjusted cost of revenues represents cost of
revenues excluding certain incremental costs incurred during our
transition to our new product line in 2023 and restructuring
charges recorded in cost of revenues in 2024. We believe adjusted
gross margin provides additional useful information with respect to
the impact of the restructuring and provides meaningful measures of
our operating performance.
(in
thousands)
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Revenues,
net
|
|
$
|
118,598
|
|
|
$
|
139,996
|
|
|
$
|
358,902
|
|
|
$
|
364,605
|
|
Discounts
on new product transition
|
|
|
—
|
|
|
|
3,124
|
|
|
|
—
|
|
|
|
12,752
|
|
Adjusted
revenues, net
|
|
|
118,598
|
|
|
|
143,120
|
|
|
|
358,902
|
|
|
|
377,357
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cost of
revenues
|
|
|
83,405
|
|
|
|
92,687
|
|
|
|
233,049
|
|
|
|
241,244
|
|
Cost of new product
transition
|
|
|
—
|
|
|
|
(2,692)
|
|
|
|
—
|
|
|
|
(5,015)
|
|
Restructuring charges
in cost of revenues
|
|
|
(12,859)
|
|
|
|
—
|
|
|
|
(12,859)
|
|
|
|
—
|
|
Adjusted cost of
revenues
|
|
|
70,546
|
|
|
|
89,995
|
|
|
|
220,190
|
|
|
|
236,229
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted gross
profit
|
|
$
|
48,052
|
|
|
$
|
53,125
|
|
|
$
|
138,712
|
|
|
$
|
141,128
|
|
Adjusted gross profit
%
|
|
|
40.5 %
|
|
|
|
37.1 %
|
|
|
|
38.6 %
|
|
|
|
37.4 %
|
|
Reconciliation of GAAP Operating Expenses to Adjusted
Operating Expenses
A reconciliation of GAAP operating expenses to the non-GAAP
measures of adjusted operating expenses is provided below. Adjusted
operating expenses represents operating expenses adjusted for
restructuring related charges in 2024 and loss on impairment of
goodwill.in 2023. We believe adjusted operating expenses provides
additional useful information with respect to the impact of the
restructuring and provides meaningful measures of our operating
performance.
(in
thousands)
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Operating
expenses
|
|
$
|
82,006
|
|
|
$
|
79,923
|
|
|
$
|
210,342
|
|
|
$
|
220,876
|
|
Restructuring related charges in operating
expenses
|
|
|
(19,832)
|
|
|
|
—
|
|
|
|
(19,832)
|
|
|
|
—
|
|
Loss on
impairment of goodwill
|
|
|
—
|
|
|
|
(6,879)
|
|
|
|
—
|
|
|
|
(6,879)
|
|
Adjusted operating
expenses
|
|
$
|
62,174
|
|
|
$
|
73,044
|
|
|
$
|
190,510
|
|
|
$
|
213,997
|
|
Reconciliation of GAAP Net Income to non-GAAP Adjusted Net
Income and Adjusted Net Income per Diluted Share
Our presentation of adjusted net income assumes that all net
income is attributable to Purple Innovation, Inc. (i.e. there is no
allocation of net income or loss to noncontrolling interests),
which assumes the full exchange at the beginning of the period of
all outstanding Paired Securities for shares of Class A common
stock of Purple Innovation, Inc., adjusted for certain nonrecurring
items that we do not believe directly reflect our core operations.
Adjusted net income per share, diluted, is calculated by dividing
adjusted net income by the total shares of Class A common stock
outstanding plus any dilutive warrants, options and restricted
stock as calculated in accordance with GAAP and assuming the full
exchange of all outstanding Paired Securities as of the beginning
of each period presented. Adjusted net loss and adjusted net loss
per diluted share, are supplemental measures of operating
performance that do not represent, and should not be considered,
alternatives to net loss and earnings per share, as calculated in
accordance with GAAP. We believe adjusted net loss and adjusted net
loss per diluted share, supplement GAAP measures and enable us to
more effectively evaluate our performance period-over-period. A
reconciliation of net loss, the most directly comparable GAAP
measure, to adjusted net loss and the computation of adjusted net
loss per diluted share, are set forth below:
(in thousands, except
per share amounts)
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Net loss
|
|
$
|
(39,310)
|
|
|
$
|
(36,135)
|
|
|
$
|
(89,587)
|
|
|
$
|
(102,841)
|
|
Income tax (benefit)
expense, as reported
|
|
|
63
|
|
|
|
18
|
|
|
|
176
|
|
|
|
162
|
|
Loss on extinguishment
of debt
|
|
|
—
|
|
|
|
3,114
|
|
|
|
3,394
|
|
|
|
4,331
|
|
Restructuring related
charges
|
|
|
32,682
|
|
|
|
—
|
|
|
|
32,682
|
|
|
|
—
|
|
Loss on impairment of
goodwill
|
|
|
—
|
|
|
|
6,879
|
|
|
|
—
|
|
|
|
6,879
|
|
Board special committee
fees
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
14,160
|
|
Acquisition
expenses
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
65
|
|
Change in fair value –
warrant liabilities
|
|
|
(4,795)
|
|
|
|
—
|
|
|
|
111
|
|
|
|
—
|
|
Adjusted net loss
before income taxes
|
|
|
(11,360)
|
|
|
|
(26,124)
|
|
|
|
(53,224)
|
|
|
|
(77,244)
|
|
Adjusted income tax
benefit(1)
|
|
|
2,942
|
|
|
|
6,766
|
|
|
|
13,785
|
|
|
|
20,006
|
|
Adjusted net
loss
|
|
$
|
(8,418)
|
|
|
$
|
(19,358)
|
|
|
$
|
(39,439)
|
|
|
$
|
(57,238)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted net loss per
share, diluted
|
|
$
|
(0.08)
|
|
|
$
|
(0.18)
|
|
|
$
|
(0.37)
|
|
|
$
|
(0.55)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted
weighted-average shares outstanding,
diluted(2)
|
|
|
107,703
|
|
|
|
105,744
|
|
|
|
107,203
|
|
|
|
103,380
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Represents the
estimated effective tax rate of 25.9% for the three and nine months
ended September 30, 2024 and 2023, applied to adjusted net income
before income taxes. The estimated effective tax rates are what the
Company would be subject to and consist of the combined federal
statutory tax rate and the Company's blended state tax rates
assuming no valuation allowance.
|
|
(2) Assumes options and
restricted stock units calculated in accordance with GAAP and the
full exchange of all outstanding Paired Securities for shares of
Class A common stock as of the beginning of the period.
|
A reconciliation of net income (loss) per share, diluted, to
adjusted net loss per diluted share is set forth below for the
three and nine months ended September 30,
2024 and 2023:
|
|
For the Three Months
Ended
|
|
|
|
September 30,
2024
|
|
|
September 30,
2023
|
|
|
|
Net
Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net
Income
per
Share,
Diluted
|
|
|
Net
Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net
Income
per Share,
Diluted
|
|
Net income (loss)
attributable to Purple
Innovation Inc.(1)
|
|
$
|
(39,228)
|
|
|
|
107,508
|
|
|
$
|
(0.36)
|
|
|
$
|
(36,004)
|
|
|
|
105,326
|
|
|
$
|
(0.34)
|
|
Assumed exchange of shares(2)
|
|
|
(82)
|
|
|
|
195
|
|
|
|
|
|
|
|
(131)
|
|
|
|
418
|
|
|
|
|
|
Net
loss
|
|
|
(39,310)
|
|
|
|
|
|
|
|
|
|
|
|
(36,135)
|
|
|
|
|
|
|
|
|
|
Adjustments to
arrive at adjusted loss
before taxes(3)
|
|
|
27,950
|
|
|
|
|
|
|
|
|
|
|
|
10,011
|
|
|
|
|
|
|
|
|
|
Adjusted loss before taxes
|
|
|
(11,360)
|
|
|
|
|
|
|
|
|
|
|
|
(26,124)
|
|
|
|
|
|
|
|
|
|
Adjusted income tax benefit(4)
|
|
|
2,942
|
|
|
|
|
|
|
|
|
|
|
|
6,766
|
|
|
|
|
|
|
|
|
|
Adjusted net loss
|
|
$
|
(8,418)
|
|
|
|
107,703
|
|
|
$
|
(0.08)
|
|
|
$
|
(19,358)
|
|
|
|
105,744
|
|
|
$
|
(0.18)
|
|
|
(1) Represents net
income (loss) attributable to Purple Innovation, Inc. and the
associated weighted average diluted shares, of Class A common stock
outstanding.
|
|
(2) Assumes the full
exchange of all outstanding Paired Securities for shares of Class A
common stock as of the beginning of the period. Also assumes the
addition of net income attributable to noncontrolling interests
corresponding with the assumed exchange of the Paired Securities
for shares of Class A common stock.
|
|
(3) Represents the
total impact of all adjustments identified in the adjusted net
income table above to arrive at adjusted income before income
taxes. Also assumes the dilutive warrants, options and restricted
stock as calculated in accordance with GAAP.
|
|
(4) Represents the
estimated effective tax rate of 25.9% for the three months ended
September 30, 2024 and 2023, applied to adjusted net income before
income taxes. The estimated effective tax rates are what the
Company would be subject to and consist of the combined federal
statutory tax rate and the Company's blended state tax rates
assuming no valuation allowance.
|
|
|
For the Nine Months
Ended
|
|
|
|
September 30,
2024
|
|
|
September 30,
2023
|
|
|
|
Net
Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net
Income
per
Share,
Diluted
|
|
|
Net
Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net
Income
per Share,
Diluted
|
|
Net loss attributable
to Purple
Innovation Inc.(1)
|
|
$
|
(89,418)
|
|
|
|
107,008
|
|
|
$
|
(0.84)
|
|
|
$
|
(102,424)
|
|
|
|
102,962
|
|
|
$
|
(0.99)
|
|
Assumed exchange of shares(2)
|
|
|
(169)
|
|
|
|
195
|
|
|
|
|
|
|
|
(417)
|
|
|
|
418
|
|
|
|
|
|
Net
loss
|
|
|
(89,587)
|
|
|
|
|
|
|
|
|
|
|
|
(102,841)
|
|
|
|
|
|
|
|
|
|
Adjustments to
arrive at adjusted loss
before taxes(3)
|
|
|
36,363
|
|
|
|
|
|
|
|
|
|
|
|
25,597
|
|
|
|
|
|
|
|
|
|
Adjusted loss before taxes
|
|
|
(53,224)
|
|
|
|
|
|
|
|
|
|
|
|
(77,244)
|
|
|
|
|
|
|
|
|
|
Adjusted income tax benefit(4)
|
|
|
13,785
|
|
|
|
|
|
|
|
|
|
|
|
20,006
|
|
|
|
|
|
|
|
|
|
Adjusted net loss
|
|
$
|
(39,439)
|
|
|
|
107,203
|
|
|
$
|
(0.37)
|
|
|
$
|
(57,238)
|
|
|
|
103,380
|
|
|
$
|
(0.55)
|
|
|
(1) Represents net loss
attributable to Purple Innovation, Inc. and the associated weighted
average diluted shares, of Class A common stock
outstanding.
|
|
(2) Assumes the full
exchange of all outstanding Paired Securities for shares of Class A
common stock as of the beginning of the period. Also assumes the
addition of net income attributable to noncontrolling interests
corresponding with the assumed exchange of the Paired Securities
for shares of Class A common stock.
|
|
(3) Represents the
total impact of all adjustments identified in the adjusted net
income table above to arrive at adjusted income before income
taxes. Also assumes the dilutive warrants, options and restricted
stock as calculated in accordance with GAAP.
|
|
(4) Represents the
estimated effective tax rate of 25.9% for the nine months ended
September 30, 2024 and 2023, applied to adjusted net income before
income taxes. The estimated effective tax rates are what the
Company would be subject to and consist of the combined federal
statutory tax rate and the Company's blended state tax rates
assuming no valuation allowance.
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/purple-innovation-reports-third-quarter-2024-results-302295829.html
SOURCE Purple Innovation, LLC